Finance News – Abbvie
What is your interest today?
Bitcoin
Crypto
Btc
Shares
Stocks
Investors
Stock
Tariffs
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Eth
Xrp
Etf
Earnings
Ipo
Bse
Stablecoin
Investment
Solana
Revenue
Blockchain
Inflation
Index
Federal Reserve
Sec
Trade
Interest Rates
Wall Street
Token
Treasury
Sensex
Coinbase
Nasdaq
Traders
Profit
Nse
Nifty
Sp 500
China
Investor
Bse Sensex
Gold
Nvidia
Company
Monetary Policy
Mines
Nydig
Fixed Mortgage Rates
Chinese
On Chain Custody
Node Operators
Double Taxation
Nc3i Network
Varonis
Hotels Sector
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jul 29, 2025
Trump's pharmaceutical tariffs could affect some drugmakers more than others
According to analyst Steve Scala, the impact of pharmaceutical tariffs may vary among companies, with AbbVie, Bristol Myers Squibb, and Eli Lilly potentially facing fewer challenge...
Read Full Article →
Business Insider Markets • Jul 23, 2025
Rheumatologists Eye AbbVieâs Rinvoq, Roche/Genentechâs Gazyva, and Bristol Myers Squibbâs Soty...
The increasing adoption of biologic therapies by U.S. rheumatologists to manage systemic lupus erythematosus indicates a growing market potential for companies developing innovativ...
Read Full Article →